Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

China Dasheng Biotechnology Company

Financial Services US CDBT

NoneUSD
0.00(0%)

Last update at 2025-09-18T20:08:59.926028Z

Day Range

--
LowHigh

52 Week Range

0.00440.08
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap2.05M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA7.72M
  • Revenue TTM20.95M
  • Revenue Per Share TTM0.70
  • Gross Profit TTM 7.50M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2008-06-30 2007-10-31 2007-06-30 2006-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2008-06-30 2007-10-31 2007-06-30 2006-06-30
Income before tax -0.96671M 5.19M -0.01000M 2.66M 1.84M
Minority interest - 1.56M 1.56M 1.34M 1.34M
Net income -0.96671M 4.64M -0.06845M 1.99M -0.01686M
Selling general administrative 0.56M 2.20M 0.01000M 1.40M 1.36M
Selling and marketing expenses - - - - -
Gross profit - 7.50M 0.00000M 4.13M 0.12M
Reconciled depreciation - - - - -
Ebit - 5.07M -0.01000M 2.75M -0.01686M
Ebitda - 5.70M - - -0.01524M
Depreciation and amortization - 0.63M - - 0.00162M
Non operating income net other - - - - -
Operating income -0.65746M 5.07M -0.01000M 2.75M -0.01686M
Other operating expenses - 11.22M - -0.02295M 0.50M
Interest expense 0.36M 0.04M 0.00000M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income -0.35983M - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.44M 0.00000M 0.00000M 0.00000M
Total revenue 0.00000M 16.29M 0.00000M 9.96M 0.48M
Total operating expenses 0.66M 2.43M 0.00000M 7.21M 0.14M
Cost of revenue - 8.79M 0.00000M 5.83M 0.37M
Total other income expense net 0.05M 0.12M 0.16M -0.09267M -0.04624M
Discontinued operations - - -0.05845M - -
Net income from continuing ops -0.96671M 5.19M -0.01000M 2.66M 1.84M
Net income applicable to common shares - 4.64M -0.06845M 1.99M 1.50M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2008-06-30 2007-10-31 2007-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2008-06-30 2007-10-31 2007-06-30
Total assets 0.48M 0.00000M 20.25M 0.01M 15.39M
Intangible assets - - 1.53M - 1.51M
Earning assets - - - - -
Other current assets - - 3.07M - 1.96M
Total liab 1.69M 0.03M 2.99M 0.08M 4.92M
Total stockholder equity -1.21381M -0.03000M 15.69M -0.06793M 9.13M
Deferred long term liab - - - - -
Other current liab 0.58M - 0.81M 0.07M 0.82M
Common stock - - 0.03M 0.01000M 3.88M
Capital stock 0.04M 0.04M - - -
Retained earnings -1.47026M 0.00000M 8.01M -0.07793M 4.42M
Other liab - - 1.46M - 1.31M
Good will - - - - -
Other assets - - 8.63M 0.01M 2.98M
Cash 0.00729M 0.00000M 1.56M - 1.32M
Cash and equivalents - - - - -
Total current liabilities 1.69M 0.03M 1.54M 0.08M 2.50M
Current deferred revenue - - - - -
Net debt 1.02M - -1.56140M - -
Short term debt - - - - 1.10M
Short long term debt 1.03M - - - 1.10M
Short long term debt total - - - - -
Other stockholder equity - - 3.85M - 0.66M
Property plant equipment - - 1.62M - 1.73M
Total current assets 0.13M 0.00000M 8.47M - 9.17M
Long term investments - - 1.00M - -
Net tangible assets - - 14.16M -0.06793M 7.62M
Short term investments 0.12M 0.00000M - - -
Net receivables - - 3.24M - 4.61M
Long term debt - - 1.46M - 1.10M
Inventory - - 0.56M - 1.29M
Accounts payable - - 0.73M 0.01000M 0.95M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - 3.81M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - 8.63M - -
Deferred long term asset charges - - - - -
Non current assets total 0.35M 0.00000M 11.78M - -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2023-06-30 2008-06-30 2007-10-31 2007-06-30 2006-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2008-06-30 2007-10-31 2007-06-30 2006-06-30
Investments 0.00622M 0.20M 0.20M - -
Change to liabilities - -0.22735M 0.03M -0.12050M -0.17281M
Total cashflows from investing activities - -3.91723M 0.00821M -0.15179M -2.18758M
Net borrowings - -0.92702M -0.92702M -0.99418M 0.45M
Total cash from financing activities 0.33M -0.92702M 0.00090M -0.99418M 0.30M
Change to operating activities - -1.70229M 0.32M -2.66498M -0.20869M
Net income -0.96671M 4.64M -0.06845M 1.99M -0.01686M
Change in cash 0.00729M 0.24M -0.00714M -0.58525M 0.00608M
Begin period cash flow 1.56M 1.32M - 0.00714M 0.00106M
End period cash flow 0.00729M 1.56M 1.32M - 0.00714M
Total cash from operating activities -0.23355M 4.10M -0.01625M 0.39M 0.00608M
Issuance of capital stock - - - - -
Depreciation - 0.63M 0.00162M 0.52M 0.00162M
Other cashflows from investing activities - 1.22M 0.00821M -0.09238M -0.09238M
Dividends paid - - - - -
Change to inventory - 0.27M 0.02M 0.44M 0.00135M
Change to account receivables - -0.12502M -1.41288M -0.43836M -0.19972M
Sale purchase of stock - - 0.00090M - -
Other cashflows from financing activities - -0.92702M - - -0.15011M
Change to netincome - 0.62M 0.62M 0.67M 0.34M
Capital expenditures 0.00000M 0.03M 5.13M 0.06M 2.15M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.04M -1.78311M - - 0.02M
Stock based compensation - - - - -
Other non cash items 0.34M 0.62M - - -
Free cash flow -0.23355M 4.07M - - 0.00608M

Peer Comparison

Sector: Financial Services Industry: Shell Companies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CDBT
China Dasheng Biotechnology Company		 - -% - - - 0.10 0.47 0.39 1.05
CLUS
CLUS		 - -% 200.00 - - 0.09 0.92 0.72 -8.9658
SVMB
SavMobi Technology Inc.		 - -% 1.00 - - 239.23 - 363.28 -319.6012
PBAJ
Petro Usa Inc		 - -% 0.0005 - - - - -9042.9978
ALSAF
ALSAF		 - -% 15.40 - - - 0.85

Reports Covered

Stock Research & News

View All

Profile

China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases. It also provides AM/HM bacteria based additives for livestock feed, which softens the livestock feed and restrain the growth and reproduction of pathogenic bacteria, as well as supplies beneficial nutriments, including organic acid, vitamins, enzyme, antibiotics, mycelium protein, and other growth-enhancing substances that balance the nutrients in the feed. In addition, the company offers FGW bacterial based preservatives that preserve animal specimens for scientific research; and preserve the freshness for agricultural produce. Further, it provides bacteria based fertilizer for application on plants, such as vegetable and fruit leaves. Additionally, China Dasheng Biotechnology Company engages in residential and commercial real estate investment. The company was formerly known as Max Nutrition, Inc. and changed its name to China Dasheng Biotechnology Company in March 2008. China Dasheng Biotechnology Company was founded in 2004 and is based in Lanzhou, China.

China Dasheng Biotechnology Company

Building B, Lanzhou, China

  • 86 93 1844 1248
  • Employees : 689

Key Executives

Name Title Year Born
Mr. Jinjun Qi Pres & Sec. 1968
Mr. Gang Chen Chairman & CEO 1963
Mr. Hongsheng Wang Chief Financial Officer 1978
Mr. Jingbo Gao VP of Investor Relations NA
Mr. Jinjun Qi President & Secretary 1968
Mr. Gang Chen Chairman of the Board & CEO 1963
Mr. Jingbo Gao Vice President of Investor Relations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions